Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel + carboplatin chemoradiotherapy for stage III–IVA cervical cancer with renal dysfunction
jRCTs031180165Active, not recruiting
- Start
- Jul 2017
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of paclitaxel and carboplatin in Cervical Cancer (CC). Primary endpoint: Discontinuance rate. Started Jul 2017; status: active, not recruiting.
02
Drugs
paclitaxelcarboplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on jRCTs031180165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180165.